Evolus, Inc. (LON: 0K16)
London
· Delayed Price · Currency is GBP · Price in USD 14.58
+0.02 (0.16%)
Jan 31, 2025, 6:17 PM BST
Evolus Employees
Evolus had 273 employees as of December 31, 2023. The number of employees increased by 58 or 26.98% compared to the previous year.
Employees
273
Change (1Y)
58
Growth (1Y)
26.98%
Revenue / Employee
575.39K GBP
Profits / Employee
-128.51K GBP
Market Cap
711.67M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 89,900 |
| GSK plc | 70,212 |
| Haleon | 25,408 |
| Smith & Nephew | 18,452 |
| Hikma Pharmaceuticals | 9,100 |
| ConvaTec Group | 10,136 |
| HUTCHMED (China) | 1,988 |
| Oxford Nanopore Technologies | 1,238 |
Evolus News
- 11 days ago - Nasdaq Jumps 100 Points; Charles Schwab Profit Beats Estimates - Benzinga
- 11 days ago - Crude Oil Down 2%; D.R. Horton Earnings Top Views - Benzinga
- 12 days ago - Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why - Investor's Business Daily
- 12 days ago - Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday - Benzinga
- 12 days ago - Evolus announces Q4 preliminary unaudited net revenue of $79M - Seeking Alpha
- 12 days ago - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Net Revenue, Achieving Record Results at the Top of the Company's Guidance - Business Wire
- 15 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 18 days ago - Evolus: Still Bullish, But Business Faces Tricky Challenges In '25 - Seeking Alpha